Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Enzyme-linked Immunosorbent Assays (ELISAs) Market: By Test Type: Sandwich ELISA, Competitive ELISA, Indirect ELISA, Multiple and Portable ELISA, Others; By Application; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Outlook
The global enzyme-linked immunosorbent assays (ELISAs) market is expected to grow at a CAGR of 3.0% during the period 2022-2027. The global market is expected to be driven by applications of enzyme-linked immunosorbent assays (ELISAs) in multiple settings, including rapid antibody screening tests for HIV, recognition of other viruses, fungi, bacteria, food allergens, autoimmune diseases, blood typing, presence of the pregnancy hormone hCG, forensic toxicology, laboratory and clinical research, and several other diagnostic settings. ELISAs are sensitive, precise, and inexpensive. These aspects are expected to drive the global market. North America, Europe and Asia are likely to be key markets.
Global Market Likely to be Driven by Applications in Various Settings
Enzyme-linked immunosorbent assay (ELISA) is a labelled immunoassay accepted as the gold standard of immunoassays. The immunological test is very sensitive and is employed to detect and quantify substances, including antibodies, antigens, proteins, glycoproteins, and hormones. There are three common variations of enzyme-linked immunosorbent assays (ELISAs) - double antibody sandwich ELISA, indirect ELISA, and competitive ELISA; these have a broad variety of applications, including clinical, forensic and food research. Recognition of cancer biomarkers for early cancer detection is a task continually being researched and developed. Enzyme-linked immunosorbent assay (ELISA) based techniques are available and employed clinically for testing for early phases of cancer (including breast and ovarian cancer).
Enzyme-linked immunosorbent assay (ELISA) is also used to determine concentrations of illegal drugs, like cannabinoids, amphetamines, opiates, cocaine, benzodiazepines, and methadone, in urine samples. Further, the method may be used to monitor levels of pharmaceutical drug concentrations in individuals under treatment, for instance, antidrug antibodies in rheumatoid arthritis and inflammatory bowel disease. Enzyme-linked immunosorbent assay (ELISA) is also usually employed to test for the detection of hormone human chorionic gonadotrophin (hCG) in urine (which is present in higher amounts in pregnant women), thus enabling easy access and home testing capabilities.
Global Market Likely to be Driven by Inexpensive and Precise Solutions Offered by Enzyme-linked Immunosorbent Assays (ELISAs)
Detection of platelet antibodies in serum is employed to recognize individuals suffering from disorders such as idiopathic thrombocytopenic purpura and systemic lupus erythematosus. These tests use alkaline phosphatase (enzyme), labelled with anti-human lgG. While being a less expensive and complicated method for detection of platelet antibodies, enzyme-linked immunosorbent assay (ELISA) is also reported to offer more than other generally employed tests, like the lymphocytotoxicity (LCT) and platelet immunofluorescence test (PIIFT). These aspects are expected to boost the global enzyme-linked immunosorbent assays (ELISAs) market.
In the food industry, enzyme-linked immunosorbent assay (ELISA) is popularly used to determine the presence of allergens for legally required ingredient labelling. The application benefits significantly from the sensitivity of ELISA and is able to detect levels of potential food allergen contaminants at concentrations on lower parts per million (ppm) scale. Further, it may be used to test for oils and other substances such as egg whites or milk, which other methods such as PCR are unable to detect.
Important Applications for Developing Countries Likely to Stimulate Market Growth
The global enzyme-linked immunosorbent assays (ELISAs) market is expected to be stimulated by an important application – detection of viruses – which is especially useful for developing countries with high infection rates. The method can reach the most susceptible groups with on-site testing capabilities and prompt results, enabling opportunistic testing.
Market Segmentation
By test type, the market is segmented into:
- Sandwich ELISA
- Competitive ELISA
- Indirect ELISA
- Multiple and Portable ELISA
- Others
By application, the market is divided into:
- Cancer
- Protein Quantification
- Immunology
- Inflammation
- Infectious Diseases
- Other
By region, the market is classified into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Industry Players in the Market
The report presents a detailed analysis of the following key players in the global enzyme-linked immunosorbent assays (ELISAs) market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- BioLegend, Inc.
- Bio-Rad Laboratories, Inc.
- Enzo Life Sciences, Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2021 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Enzyme-linked Immunosorbent Assays Market Analysis
8.1 Key Industry Highlights
8.2 Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market (2017-2021)
8.3 Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast (2022-2027)
8.4 Global Enzyme-linked Immunosorbent Assays (ELISAs) Market by Test Type
8.4.1 Sandwich ELISA
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Competitive ELISA
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Indirect ELISA
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Multiple and Portable ELISA
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.4.5 Others
8.5 Global Enzyme-linked Immunosorbent Assays (ELISAs) Market by Application
8.5.1 Cancer
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Protein Quantification
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Immunology
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Inflammation
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Infectious Diseases
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Other
8.6 Global Enzyme-linked Immunosorbent Assays (ELISAs) Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Thermo Fisher Scientific Inc.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Becton, Dickinson and Company
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 BioLegend, Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Bio-Rad Laboratories, Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Enzo Life Sciences, Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market: Key Industry Highlights, 2017 and 2021
2. Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Test Type (USD Million), 2017-2021
3. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Test Type (USD Million), 2022-2027
4. Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Application (USD Million), 2017-2021
5. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Application (USD Million), 2022-2027
6. Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Region (USD Million), 2017-2021
7. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Region (USD Million), 2022-2027
8. North America Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
9. North America Enzyme-linked Immunosorbent Assays (ELISA) Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Europe Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
11. Europe Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Asia Pacific Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
13. Asia Pacific Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Latin America Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
15. Latin America Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Middle East and Africa Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2021
17. Middle East and Africa Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Structure
Key Questions Answered in the Report
The global enzyme-linked immunosorbent assays (ELISAs) market is projected to grow at a CAGR of 3.0% between 2022 and 2027.
The major drivers of the market include the increasing demand for cost-effective diagnostic tools, growing applications of ELISA in multiple settings, such as rapid antibody screening tests for HIV, rising need for frequent diagnostic testing, and increasing geriatric population.
The growing applications of ELISA in oncology and the rising incidence of infectious diseases and cancer are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Based on test type, the market is segmented into sandwich ELISA, competitive ELISA, indirect ELISA, multiple and portable ELISA, among others.
The significant applications of the market include cancer, protein quantification, immunology, inflammation, and infectious diseases, among others.
The major players in the industry are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, BioLegend, Inc., Bio-Rad Laboratories, Inc., and Enzo Life Sciences, Inc., among others.
Analyst Review
The global enzyme-linked immunosorbent assays (ELISAs) market was driven by the rising incidence of infectious diseases and cancer in the historical period. Aided by the growing applications of ELISA in multiple settings, such as rapid antibody screening tests for HIV and rising need for frequent diagnostic testing, the market is expected to grow at a CAGR of 3.0% in the forecast period of 2022-2027.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on test type, the market is segmented into sandwich ELISA, competitive ELISA, indirect ELISA, multiple and portable ELISA, among others. The significant applications of the market are cancer, protein quantification, immunology, inflammation, and infectious diseases, among others. The major regional markets for enzyme-linked immunosorbent assays (ELISAs) are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, BioLegend, Inc., Bio-Rad Laboratories, Inc., and Enzo Life Sciences, Inc., among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global bone morphogenetic proteins market was driven by the increasing number of people suffering from spinal injuries in the historical period. Aided by the rising geriatric population and establ...
The global blood group typing market attained a value of nearly USD 2 billion in 2021, driven by the growing demand for blood due to the rising cases of accidents. Aided by the rising awareness regard...
The global assisted reproductive technology market attained a value of USD 28.35 billion in 2021, driven by the increasing infertility cases. Aided by the rising consumption of unhealthy food and incr...
The global clinical laboratory services market was driven by the widening scope of clinical laboratory services in the historical period. Aided by the launch of technologically advanced products and a...
The global biological safety testing market attained a value of USD 3.5 billion in 2021, driven by the thriving biopharmaceutical industry. Aided by the increasing efforts by pharmaceutical and life s...
NEWSLETTER